Literature DB >> 11673032

Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections.

R Daza1, J Gutiérrez, G Piédrola.   

Abstract

Isolates from urine samples obtained during 1999 were identified and their susceptibility to antimicrobial agents studied along with any production of extended-spectrum beta-lactamases (ESBL) by Escherichia coli and Klebsiella pneumoniae. A total of 13774 samples were analysed using an automatic system for the detection of bacterial ATP (Coral, USA). Of these samples, 49% were reported to be positive and uncontaminated; bacteria most frequently isolated were E. coli (47%), Proteus mirabilis (7%), Enterococcus faecalis (6%) and K. pneumoniae (5%). The susceptibility studies showed 37% E. coli strains resistant to amoxycillin+clavulanate 33% to cotrimoxazole and 22% to ciprofloxacin. Seven strains of E. coli produced ESBL. Thirteen per cent of strains were resistant to cefuroxime but only (1%) to fosfomycin. Resistance to nitrofurantoin in K. pneumoniae was 38%. P. mirabilis showed 52% resistance to cotrimoxazole and 13% Staphylococcus aureus, were methicillin-resistant. E. faecalis did not show any special resistance to normal medication. Fosfomycin continued to show high activity against Gram-negative bacilli. However, enterococci, some species of staphylococci and yeasts were difficult to treat empirically. ESBL were detected in the isolates of E. coli and there were some methicillin-resistant strains of S. aureus.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11673032     DOI: 10.1016/s0924-8579(01)00389-2

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  25 in total

1.  Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients.

Authors:  Jesús Rodríguez-Baño; Maria Dolores Navarro; Luisa Romero; Luis Martínez-Martínez; Miguel A Muniain; Evelio J Perea; Ramón Pérez-Cano; Alvaro Pascual
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

2.  Evaluation of two automated systems for detection of bacteriuria.

Authors:  José Gutiérrez; Antonio Sorlózano; María José Soto; Gonzalo Piédrola
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

3.  Rapid and simple determination of ciprofloxacin resistance in clinical strains of Escherichia coli.

Authors:  Rebeca Santiso; María Tamayo; José Luis Fernández; María del Carmen Fernández; Francisca Molina; Rosa Villanueva; Jaime Gosálvez; Germán Bou
Journal:  J Clin Microbiol       Date:  2009-07-01       Impact factor: 5.948

4.  Clinical and molecular analysis of extended-spectrum {beta}-lactamase-producing enterobacteria in the community setting.

Authors:  Corinne Arpin; Véronique Dubois; Jeanne Maugein; Jacqueline Jullin; Brigitte Dutilh; Jean-Philippe Brochet; Gilberte Larribet; Isabelle Fischer; Claudine Quentin
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

5.  Risk factors for non-Escherichia coli community-acquired bacteriuria.

Authors:  M A Amna; B Chazan; R Raz; H Edelstein; R Colodner
Journal:  Infection       Date:  2012-10-11       Impact factor: 3.553

Review 6.  A reappraisal of current dosing strategies for intravenous fosfomycin in children and neonates.

Authors:  Friederike Traunmüller; Martin Popovic; Karl-Heinz Konz; Patrick Vavken; Andreas Leithner; Christian Joukhadar
Journal:  Clin Pharmacokinet       Date:  2011-08       Impact factor: 6.447

7.  Pathological and therapeutic significance of cellular invasion by Proteus mirabilis in an enterocystoplasty infection stone model.

Authors:  Rejiv B Mathoera; Dik J Kok; Cees M Verduin; Rien J M Nijman
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

8.  What is true community-acquired urinary tract infection? Comparison of pathogens identified in urine from routine outpatient specimens and from community clinics in a prospective study.

Authors:  T Y Ti; G Kumarasinghe; M B Taylor; S L Tan; A Ee; C Chua; A Low
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-22       Impact factor: 3.267

9.  Prevalence of community-occurring extended spectrum beta-lactamase-producing Enterobacteriaceae in Brazil.

Authors:  Luciene A R Minarini; Ana C Gales; Izabel C V Palazzo; Ana Lúcia C Darini
Journal:  Curr Microbiol       Date:  2007-04-24       Impact factor: 2.188

Review 10.  Evaluation of antimicrobial susceptibility of Enterobacteriaceae causing urinary tract infections in Africa.

Authors:  Giannoula S Tansarli; Stavros Athanasiou; Matthew E Falagas
Journal:  Antimicrob Agents Chemother       Date:  2013-05-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.